Data from our 24-month randomized trial on patients affected by Barrett’s esophagus suggest that a calorie and protein restriction program together with a specialized supervised approach can affect IGF-1 serum levels, reducing its secretion and also the IGF-1/IGFBP3 ratio. Here, IGFBP3 is linked to esophageal adenocarcinoma.